Catherine Schulte
Stock Analyst at Baird
(4.02)
# 525
Out of 4,876 analysts
130
Total ratings
54.55%
Success rate
9.82%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $159 → $140 | $119.42 | +17.23% | 16 | May 22, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.38 | -15.97% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $51.81 | +38.97% | 14 | May 2, 2025 | |
| AVTR Avantor | Maintains: Outperform | $21 → $17 | $13.74 | +23.73% | 11 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $603 → $573 | $412.12 | +39.04% | 26 | Apr 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $231 → $225 | $201.46 | +11.68% | 9 | Apr 23, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,369 → $1,034 | $1,193.31 | -13.35% | 8 | Apr 22, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $48.04 | -10.49% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $52.80 | +28.79% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $19.78 | +92.11% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $36.94 | -10.67% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $94.16 | +198.43% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $354.91 | -38.86% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $168.17 | -88.11% | 1 | Jun 28, 2018 |
Agilent Technologies
May 22, 2025
Maintains: Outperform
Price Target: $159 → $140
Current: $119.42
Upside: +17.23%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.38
Upside: -15.97%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $51.81
Upside: +38.97%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $21 → $17
Current: $13.74
Upside: +23.73%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $603 → $573
Current: $412.12
Upside: +39.04%
Danaher
Apr 23, 2025
Maintains: Outperform
Price Target: $231 → $225
Current: $201.46
Upside: +11.68%
Mettler-Toledo International
Apr 22, 2025
Maintains: Neutral
Price Target: $1,369 → $1,034
Current: $1,193.31
Upside: -13.35%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $48.04
Upside: -10.49%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $52.80
Upside: +28.79%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $19.78
Upside: +92.11%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $36.94
Upside: -10.67%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $94.16
Upside: +198.43%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $354.91
Upside: -38.86%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $168.17
Upside: -88.11%